Losartan and lercanidipine attenuate low-density lipoprotein oxidation in patients with hypertension and type 2 diabetes mellitus: A randomized, prospective crossover study*
2002 ◽
Vol 72
(3)
◽
pp. 302-307
◽
1999 ◽
Vol 18
(5)
◽
pp. 451-461
◽
2014 ◽
Vol 18
(1)
◽
pp. 94
◽
2005 ◽
Vol 1051
(1)
◽
pp. 97-103
◽
2016 ◽
Vol 111
◽
pp. 66-73
◽
2015 ◽
Vol 13
(2)
◽
pp. 84-90
◽
2002 ◽
Vol 89
(7)
◽
pp. 825-829
◽
2014 ◽
Vol 34
(3)
◽
pp. 676-683
◽